Eosinophilic Granulomatosis with Polyangiitis: Where Are We with Diagnosis and Management?
| Overview / Abstract: |
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disseminating vasculitis that has a heterogeneous presentation. Because of this and its infrequent occurrence, it is often not considered in the differential diagnosis of patients presenting with vasculitis. Diagnosis is further complicated by the lack of diagnostic criteria, causing most patients to experience diagnostic delays. In addition, there is little in the way of guidance for rheumatologists with respect to managing EGPA. In 2017, mepolizumab became the first agent approved by the FDA for the management of EGPA. This activity, "Eosinophilic Granulomatosis with Polyangiitis: Where Are We with Diagnosis and Management?," will provide rheumatologists with strategies to more efficiently diagnose EGPA, develop individualized management plans, and recognize and manage disease relapse. |
|
Expiration |
Apr 24, 2021 |
|
Discipline(s) |
Physician CME |
|
Format |
Webinar / Webcast / Video |
|
Credits / Hours |
1.0 |
|
Accreditation |
ACCME, ABIM MOC |
|
Presenters / Authors / Faculty |
Rula A. Hajj‐Ali, MD, FACP Michael Wechsler, MD |
|
Activity Specialities / Related Topics |
Rheumatology / Arthritis, Primary Care |
|
Sponsors / Supporters / Grant Providers |
This educational activity is supported by an educational grant from GlaxoSmithKline. |
|
Keywords / Search Terms |
Rockpointe Free, CME, ABIM MOC, EGPA, Eosinophilic granulomatosis with polyangiitis, rheumatology, rheumatologists Free CE CME |
|